Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. If cleared by the Food and Drug Administration—a decision that could…
Read More
FDA may approve mixing and matching COVID-19 booster shots
Fox News Flash top headlines for October 20 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The U.S. Food and Drug Administration (FDA) is expected to allow the mixing and matching of COVID-19 vaccine booster…
Read More
FDA strikes neutral tone ahead of vaccine booster meeting
Influential government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective—the first step toward deciding which Americans need one and when. The Food and Drug Administration on Wednesday posted…
Read More
U.S. FDA set to authorize COVID-19 vaccine boosters for immunocompromised patients – NBC News
FILE PHOTO: Fourth-year medical student Anna Roesler administers the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at Indiana University Health, Methodist Hospital in Indianapolis, Indiana, U.S., December 16, 2020. REUTERS/Bryan Woolston(Reuters) – The U.S. Food and Drug Administration is expected to authorize…
Read More
FDA notifies Amazon over sale of certain harmful sexual enhancement products
(Reuters) -The U.S Food and Drug Administration (FDA) notified Amazon.com Inc over the sale of sexual enhancement and weight-loss products that had potentially harmful drug ingredients, in a letter addressed to the company’s new boss Andy Jassy.FILE PHOTO: Signage is…
Read More
FDA Approves Rezurock
FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved…
Read More
Lilly to seek FDA approval for new Alzheimers drug
Fresh on the heels of the U.S. Food and Drug Administration’s approval of the controversial Alzheimer’s drug Aduhelm, the maker of a second medicine that works in similar fashion said Thursday it hopes to apply for approval of its medication…
Read More
Three FDA advisers quit over agency approval of aduhelm
Three members of a U.S. Food and Drug Administration advisory committee have resigned after the agency this week approved a new drug for Alzheimer disease despite a lack of strong proof that it provides any benefits to patients. Aduhelm (aducanumab)—a…
Read More
FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'
Fox News Flash top headlines for June 8 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. WASHINGTON – Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years,…
Read More
U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug…
Read More